Back to Journals » Biologics: Targets and Therapy

Biologics: Targets and Therapy


ISSN: 1177-5491

ISSN: 1177-5475 (Print) - went to online only in 2009

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.


This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

 

 

  

 

Indexed online:  

 

  • Emerging Sources Citation Index (ESCI), from 2016
  • PubMed and PubMed Central (Biologics)
  • Embase, from 2009 (Correct as at December 8, 2016)
  • Scopus, from 2009 (Correct as at December 8, 2016)
  • Directory of Open Access Journals (DOAJ)
  • OAIster: The Open Access Initiative

Latest articles:

- 5 records -

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy

Hawkins ER, D'Souza RR, Klampatsa A

Biologics: Targets and Therapy 2021, 15:95-105

Published Date: 14 April 2021

Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7

Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K

Biologics: Targets and Therapy 2021, 15:87-94

Published Date: 13 April 2021

Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon

O'Donnell KL, Marzi A

Biologics: Targets and Therapy 2021, 15:79-86

Published Date: 18 March 2021

Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature

Bounia CA, Theodoropoulou EN, Liossis SNC

Biologics: Targets and Therapy 2021, 15:61-66

Published Date: 17 March 2021

 

Read more articles